325 related articles for article (PubMed ID: 16762236)
1. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
Chen N; Yang YT; Dong XG; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of different antifungal treatment regimens for experimental Candida endophthalmitis in rabbit models].
Koçak N; Kaynak S; Kirdar S; Irmak O; Bahar IH
Mikrobiyol Bul; 2009 Oct; 43(4):619-26. PubMed ID: 20084915
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits.
Liu KR; Peyman GA; Khoobehi B
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1527-34. PubMed ID: 2787300
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
[TBL] [Abstract][Full Text] [Related]
6. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
[TBL] [Abstract][Full Text] [Related]
7. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
Yan XR; Dong XG; Chen N; Wang W
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
[TBL] [Abstract][Full Text] [Related]
8. Vitrectomy in experimental endophthalmitis: Part I-Fungal infection.
Huang K; Peyman GA; McGetrick J
Ophthalmic Surg; 1979 Mar; 10(3):84-6. PubMed ID: 460810
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy with fluconazole infusion: retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis.
Cheng CK; Yang CH; Hsueh PR; Liu CM; Lu HY
J Ocul Pharmacol Ther; 2004 Oct; 20(5):430-8. PubMed ID: 15650518
[TBL] [Abstract][Full Text] [Related]
10. Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Yang L; Dong X; Wu X; Xie L; Min X
Retina; 2011 Oct; 31(9):1791-800. PubMed ID: 21606889
[TBL] [Abstract][Full Text] [Related]
11. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B methyl ester: evaluation for intravitreous use in experimental fungal endophthalmitis.
McGetrick JJ; Peyman GA; Nyberg MA
Ophthalmic Surg; 1979 Jul; 10(7):25-9. PubMed ID: 314613
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model.
Karagoz E; Ugan RA; Duzgun E; Cadirci E; Keles S; Uyanik MH; Yavan I; Turhan V
Curr Eye Res; 2017 Feb; 42(2):225-232. PubMed ID: 27348425
[TBL] [Abstract][Full Text] [Related]
14. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
15. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and efficacy of vitrectomy fluids: amphotericin B methyl ester in the treatment of experimental fungal endophthalmitis.
Raichand M; Peyman GA; West CS; Hammond G; Zweig K
Ophthalmic Surg; 1980 Apr; 11(4):246-8. PubMed ID: 6966778
[TBL] [Abstract][Full Text] [Related]
18. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B in the therapy of Candida glabrata endophthalmitis after penetrating keratoplasty.
Grueb M; Rohrbach JM; Zierhut M
Cornea; 2006 Dec; 25(10):1243-4. PubMed ID: 17172909
[TBL] [Abstract][Full Text] [Related]
20. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
Qu L; Li L; Xie H
Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
